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Summary Flunarizine is a class IV calcium channel blocker which increases oxygen delivery to hypoxic
regions in solid tumours, exerting a radiosensitising effect in vivo in animal tumour models. Precisely how the
drug improves oxygenation is not well understood. We hypothesised that metabolic conditions present within
solid tumours reduce red blood cell (RBC) deformability and that flunarizine exerts its in vivo effect by
preventing this loss of RBC deformability. A microrheometer was used to compare the viscosity of rat and
human RBC suspensions in conditions of hypoxia (PO2<10mmHg), acidic environment (pH6.8), and
elevated lactate concentration (lactate 5 mMol I ), without or with flunarizine at concentrations of 5, 10, and
50 mg '-l. The effects of flunarizine on RBC density and morphology were also recorded. Hypoxia, low pH,
and lactate exposure together increased both human and rat RBC suspension viscosity. Flunarizine at
concentrations of 5 and 10 mg I -l prevented the increases in viscosity. The drug caused dose-dependent shifts
toward lower cell density while inducing a characteristic cupped shape (stomatcytic morphology), suggesting a
mechanism involving calmodulin inhibition. The results support the hypothesis that flunarizine improves
tumour blood flow and oxygenation by enhancing flow properties of RBC's in solid tumours.
Attempts have been made to use a variety of blood flow
modifiers in an effort to improve oxygen delivery to hypoxic
regions of tumours, thereby enhancing radiosensitivity (Hor-
sman et al., 1991). Blood flow in tumour microvasculature
involves complex interactions of cellular elements, variable
pressure gradients, and irregular vessel morphology (Jain,
1988). However, in very small vessels and capillaries, the
deformability of the individual erythrocyte (RBC) becomes
increasingly more important as the discoid cell must fold
over onto itself in order to navigate through passageways
often smaller than its own diameter. Indeed, there exists
direct evidence of the impact of altered RBC deformability
on the apparent in vivo blood viscosity in tumour micro-
circulation. For example, Sevick and Jain have used hyper-
glycemia to induce slight cell volume changes which impair
RBC deformability, thus causing measurable increases in the
pressure gradient required for equivalent flow rates across
tumour vascular beds (1991).
An agent capable ofimproving the deformability of RBC's
might be useful in the enhancement of radiosensitivity if
there is reason to believe that loss of deformability selectively
occurs within the environment of the tumour, thus com-
promising blood flow and oxygen delivery there. Prominent
characteristics of tumour centres include significant hypoxia
and the lactic acidosis which may result in such circum-
stances (Vaupel et al., 1989), and it has recently been
confirmed by direct measurement that PO2 within flowing
tumour vessels may be lower than 10 mmHg (Dewhirst et al.,
1992a). It was our specific intention to determine whether
such environmental conditions adversely affect the deform-
ability of erythrocytes. Also, it was our goal to assess wheth-
er flunarizine has activity in these conditions in reversing any
loss of RBC deformability.
Flunarizine (E- 1-[bis(4-fluorophenyl)methyl]-4-(3-phenyl-
2-propenyl)piperazine dihydrochloride) is a WHO class IV
calcium-entry blocking agent which enhances radiosensitivity
in vivo in animal models (Wood & Hirst, 1988). Numerous
studies have demonstrated that the drug significantly im-
proved blood flow and oxygenation in the hypoxic regions of
tumours implanted experimentally in animals (Kaelin et al.,
1984; Vaupel & Menke, 1987; Fenton & Sutherland, 1992).
Since this effect was not associated in our most recent studies
with changes in tumour vessel pressure gradients, diameters,
density, or morphology (Dewhirst et al., 1992b), we have
hypothesised that the drug exerts an effect on the viscosity of
blood flowing through tumour microvasculature.
In order to investigate the rheological properties of RBC's
in controlled conditions of low P02, low pH, and excess
lactate concentration which simulate the in vivo milieu of
hypoxic tissues, a closed chamber microrheometer (Tran-Son-
Tay et al., 1988) was used to test the viscosity of rat and
human RBC suspensions. The cells were exposed to the
tumour-like conditions either untreated or pre-treated with
flunarizine over a concentration range known to be effective
in reducing hypoxia in animal tumour models. The rheometer
then measured the viscosity of a packed suspension of
erythrocytes. Although the device did not differentiate the
various components of individual cell deformability (i.e.
membrane visco-elastic properties and internal viscosity) in
the manner of pipette studies, nevertheless it provided an
indication of changes in deformability averaged over a
population of cells. Most importantly in these experiments,
the device had the advantage of being a closed chamber in
which environmental conditions such as PO2 could be tightly
controlled.
Methods
Preparation oferythrocyte suspensions
Whole blood from human donors was collected by venipunc-
ture into vacutainers using heparin as an anticoagulant.
Blood from Fisher rats was obtained via ventricular puncture
under general anaesthesia with pentobarbital. The whole
blood was washed in Hepes (Research Organics, Cleveland,
OH) buffered saline (HBS) of pH 7.4 and centrifuged at
3000 r.p.m. for 15 min in a refrigerated centrifuge (IEC
model DPR-6000, Needham Heights, MA) at 15°C. The
plasma/HBS mixture and buffy coat were removed by pipette
aspiration, and the remaining red blood cells were washed
twice more in HBS.
The RBC's were then re-suspended to a 10% hematocrit in
either HBS (control) or HBS adjusted to the desired experi-
mental condition. In all treatments the osmolarity of the
suspending medium was held within the range of 290-
300 mOsm 1-1, verified by a freezing point depression osmo-
meter (Advanced Instruments model 3W2, Needham Heights,
MA). The pH of the media was verified by an electrode-type
pH meter (Orion Research SA 230, Cambridge, MA).
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For treatment in conditions of low pH, the relative pro-
portions of Hepes acid and Hepes buffer salt were adjusted
to yield solutions of pH 6.8 (range 6.67-6.85). Exposure to
lactate was achieved by dissolving a sufficient quantity of
sodium lactate (Sigma, St. Louis, MO) in HBS of pH 7.4 or
6.8 in order to obtain lactate concentrations of 5 mMol l-,
maintaining osmolarity between 290-300 mOsm `'. Flunari-
zine (Janssen Pharmaceuticals, Beerse, Belgium) was added
from stock aqueous solutions of concentration 0.5 or
1.0 mg ml-'. The solutions were prepared by dissolving
5-10 mg of flunarizine into 1.0 ml of filtered 95% aqueous
ethanol to which 9.0 ml of de-ionised water was then added.
The mixture was vortexed for 10 min to enhance entry into
solution. With a digital pipettor, the flunarizine solution was
added to the HBS of pH 7.4 or the low pH lactate solutions
in order to achieve concentrations of 5, 10, or 50 mg I';
iso-osmolar conditions were maintained by adding de-ionised
water or sodium chloride as needed.
After exposure to HBS at pH 7.4 (normal control) or to
the adjusted experimental solution for 20-30 min, the 10%
hematocrit suspensions were centrifuged for 20 min at
1700 r.p.m. at 15°C. A sufficient amount of supernatant was
removed to yield a hematrocrit of 90%. The final hematocrit
was checked by capillary tube centrifugation. Values from
88-92% were considered acceptable for testing. Suspensions
outside the range 88-92% were adjusted either by adding
back a small amount of the removed supernatant or
repeating the centrifugation and removing additional super-
natant.
De-oxygenation
Hypoxia was achieved by exposing the 90% hematocrit
suspensions to a humidified 95% N2/5% CO2 gas mixture.
The pH of the suspension was not altered by this treatment.
After preparation as described above, 0.5-1.0 ml of the
erythrocyte suspension was collected into a 1.0 ml syringe
and injected into a 25-30 cm length of 0.635 cm ID Silastic
(Dow Corning, Midland, MI) tubing which was suspended
along the inner walls of a 30 x 30 x 40 cm Lucite.m glove
box. The hinged box top was sealed airtight with vacuum
grease and clamped. The N2/CO2 mixture was humidified by
bubbling through two water-containing beakers before being
introduced into the glove box via an inlet valve. After 20 min
continuous flow through the 1.0 cm diameter inlet valve at
8-1O psi, a PO2 of less than 3 mmHg inside the box was
obtained. Exposure of the suspensions to the hypoxic gas
mixture for 90 min yielded blood PO2 of less than 10 mmHg.
Gas and blood PO2 levels were verified with a blood gas
analyser (Model ABL 30, Radiometer, Copenhagen). The
suspensions of RBC's were easily recovered from the Silastic
tubing by aspiration back into the syringe.
Density profile measurements
Small aliquots (50-100Ll) of the erythrocyte suspensions
were injected into two capillary tubes to which a droplet of
phthalate ester oils of known density (either 1.095 or
1.105 gml-') was added. The cells were then centrifuged at
13,450g for 3 min (IEC model MB, Needham Heights, MA).
Following centrifugation the cells were apportioned into
three compartments. 'Low density' cells were less dense than
the lighter oil (< 1.095 gml-'), and 'high density' cells were
more dense than the heavier oil (>1.105 gml-'). The
remaining cells were of intermediate density (1.095-1.105
gml-').
Microrheometer
A magneto-acoustic ball microrheometer was used to per-
form viscosity measurements in a manner previously des-
cribed in detail (Tran-Son-Tay et al., 1988 and 1989). A
10 mm glass tube of 1.6 mm inside diameter was placed
vertically within a Lucite.T water jacket, sealed watertight at
each end with rubber o-rings; the temperature of the water
bath was held at 25°C. A gold-plated lead zirconate titanate
(PZT-SA) piezoelectric crystal was positioned beneath the
glass tube. Approximately 20fsl of the treated RBC suspen-
sion was slowly injected into the glass tube, and then a
stainless steel ball of diameter 1.3 mm was carefully placed
into the suspension. The top of the glass tube was sealed with
a glass coverslip. In experiments involving hypoxic cells,
loading the inner chamber was accomplished inside the glove
box within an atmosphere of low PO2-
An electromagnet with a DC field was used to levitate and
stabilise the steel ball by counterbalancing gravitational
forces. Ultrasonic waves were generated by applying an elec-
trical pulse to the PZT-SA crystal; waves emitted into the
suspension were reflected from the base of the ball and
received back at the base of the glass tube. The time required
for the sound wave to travel up and back down (time of
flight) was tracked. The height of the ball above the crystal is
determined by the product of the speed of sound in the
suspension and the measured time of flight. When the DC
power to the electromagnet is turned off, the steel ball falls
under the influence of gravity. The viscosity of the suspen-
sion may be calculated from the terminal velocity of the steel
ball (Tran-Son-Tay et al., 1988).
Morphological studies
Washed rat and human erythrocytes were exposed to low
(10mgI1) or high (50 mgI1) concentrations of flunarizine
in HBS and compared to untreated cells suspended in HBS
alone. The suspensions were diluted to approximately 2%
hematocrit to allow settling to a thin layer within a glass
slide chamber. Observations of RBC morphology were made
using a Leitz Diavert bright field microscope (Leitz, Ger-
many) with a 200 W mercury lamp. Images were recorded on
3/4" videotape for subsequent analysis. Stomatocytes are
cells with a characteristic cupped shape when seen in profile
or else mouth-like folding of the membrane when seen en
face, as described by Bessis (1973). The alteration from the
normal discoid morphology results from the release of por-
tions of the membrane at the centre of the disc from points
at which they are tethered to the inner cytoskeleton of cyto-
plasmic proteins, thus leaving only one-sided invagination of
the membrane that yields the cupped shape. The cells are
readily identified by light microscopy, and the proportion of
stomatocytes among the total population of RBC's is easily
scored.
Statistics
Individual data points on Figures 1 to 4 represent values
obtained from blood samples of five healthy human
volunteers, mean + s.e., or three healthy rats, mean ± s.d.
Variability between rats was minimal (mean values were
within + 5-10% of each other), and all rat data have been
pooled for simplicity. For each individual human or rat
subject, at least 5-10 repetitions of the falling ball experi-
ment were performed. Quoted percentages of stomatocytes
represent the average ± s.d. of at least four samples in which
at least 150 cells were counted. The t-test has been used for
comparisons between results obtained under any two sets of
circumstances.
Results
Isolated effects ofhypoxia, excess lactate, lowpH, and
flunarizine
In order to assess the individual contributions of hypoxia,
elevated lactate concentration, and low pH to possible
changes in the viscosity of the erythrocyte suspensions, initial
experiments were conducted to determine how each of these
conditions individually might alter viscosity. The isolated
effect of flunarizine at a concentration of 10 mg l-' was also
tested. The percentage changes in viscosity are shown in736 B.D. KAVANAGH et al.
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Figure 1 Percentage change in RBC suspension viscosity in human (black bars) and rat (white bars) cells with the addition of
flunarizine (10 mg 1-1), in low pH (pH 6.8), with high lactate concentration (5 mMol 1-'), in extreme hypoxia (PO2<10 mmHg), or
in extreme hypoxia and lactic acid (pO2<10 mmHg, pH 6.8, lactate 5 mMol- 1') combined.
* Human
Rat
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+flu (10 mg l-1) +flu (50 mg l-1)
Figure 2 Absolute viscosity of human (black bars) and rat (white bars) RBC suspensions in control conditions (pH 7.4, P02
150 mmHg) and in an environment of combined hypoxia (PO2<10 mmHg) and lactic acid (pH 6.8, lactate 5 mMol 1'), without or
with flunarizine at 5, 10, and 50mgI 1.
Figure 1. The effect of injecting cell suspensions into the
Silastic tubing was tested as a control; no change in
measured suspension viscosity or density profile was observed
(data not shown).
In human RBC's flunarizine caused a 15% decrease in
viscosity, significantly different from baseline (P = 0.03).
Similarly, exposure of cells to low pH reduced viscosity by
11%, a result also approaching statistical significance
(P = 0.1). Notably, for either of these experimental condi-
tions, in any individual case significant changes were only
observed in individuals whose baseline mean viscosity was
above 18 cP. In each of these cases, after treatment with
flunarizine or exposure to low pH, viscosity fell to values
between 12 and 17 cP, nearer to the minimum measured
values among all studies. In all cases without response to
either flunarizine or low pH the baseline control viscosity
(mean values 14 and 15cP) was lower initially. Although
lactate caused a mean increase in viscosity, the effect was
widely variable and was not statistically significant (P = 0.3).
Hypoxia increased viscosity in all five individuals tested. The
average increase was 23%, which was statistically significant
(P<0.01). Exposure of the red blood cells simultaneously to
hypoxia, low pH, and lactate resulted in an increase in
viscosity in four of five individuals, with an average change
of 14% above baseline (P = 0.2).
In rat blood qualitatively similar trends were observed in
most instances, as seen in Figure 1, with the conspicuous
exception of exposure to lactate. Flunarizine and low pH
decreased viscosity by 30 + / - 4.3% and 17 + / - 6%,
respectively. After exposure to lactate, an overall average net
decrease from baseline of 9 + / - 4.5% was observed.
Hypoxia increased viscosity of the suspensions by approx-
imately 26 + / - 9.5%. The combined effect of hypoxia, low
pH, and lactate combined produced an even greater increase
in viscosity, on the order of 38 + / - 10% above baseline. All
changes from baseline were significant (P<0.05).
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Combined effects ofhypoxia, excess lactate, and lowpH and
response to varying concentrations offlunarizine
Illustrated in Figure 2 are the absolute viscosities of suspen-
sions of RBC's pre-treated with flunarizine in concentrations
of 5, 10, and 50 mg 1-1 prior to exposure to hypoxia, low pH,
and lactate. In humans, relative to the viscosity measured
under these conditions without drug, treatment with
flunarizine produced a decrease in viscosity at all concentra-
tion levels (P = 0.06, 0.02, and 0.06, respectively for 5, 10,
and 50 mgI1). The magnitude of the change observed at
1Omg' 1 ranged from 8% to 46%. In rat blood the results
were qualitatively similar except at the highest dose level,
where viscosity rose back to values equal to those obtained in
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the combination of hypoxia, low pH, and lactate. Viscosity
was significantly increased at a concentration of 50 mg 1'
compared to the nadir observed at 5 and 10 mg1'
(P<0.05).
Densityprofile studies
Changes in the cell density distribution generall paralleled
changes in viscosity measurements, with shifts toward
decreased cell density accompanying decreases in suspension
viscosity. In Figure 3 are the human red cell density profiles
observed after exposure to flunarizine (10 mg 1-), low pH,
hypoxia, and excess lactate concentration, with the average
normal (control) distribution depicted for comparison. It can
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Figure 3 Proportions of cells of low, intermediate, and high density for human (lower graph) and rat (upper graph) RBC's with
the addition of flunarizine (1Omg1'), in low pH (pH 6.8), in control conditions (pH 7.4, P02 150mmHg), with high lactate
concentrations (5 mMol 1-'), or in extreme hypoxia (PO2< 10 mmHg). Solid black bar (_) represents high density cells
(>1.105 gml-'), stippled bar (Ml) represents intermediate density cells (1.095-1.105 gml-'), and white bar (El) represents
low density cells (<1.095 g ml-').
Low pH, lactate,
hypoxia
+flu (5 mg 1-1) +flu (10 mg 1-')
Figure 4 Proportions of cells of low, intermediate, and high density for human (lower graph) and rat (upper graph) RBC's in
hypoxia and lactic acid (PO22<10 mmHg, pH 6.8, lactate 5 mMol -') without or with flunarizine at 5, 10, and 50mgI 1. Solid
black bar (_) represents high density cells (>1.105gml-'), stippled bar (M) represents intermediate density cells
(1.095-1.105 g ml-'), and white bar (El) represents low density cells (<1.095 g ml-).
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Figure 5 Representative photomicrograph (approx. 1500 x magnification) of human RBC's (a) before and (b) after exposure to
flunarizine (50 mg [ ').
be seen that both flunarizine and low pH shift the cells
toward lower density. The presence of lactate had no net
effect, whereas exposure to hypoxia increased cell density.
Although there was variability in degree of change among
individuals (error bars not shown), the percentage of cells
with lowest density changed significantly after exposure to
flunarizine, low pH, or hypoxia relative to control conditions
(P<0.05 in all cases). Again, qualitatively similar effects
were noted in the rat cells, as illustrated in Figure 3.
When RBC's were pre-treated with flunarizine prior to
exposure to hypoxia, low pH, and lactate, a dose-dependent
shift toward lower cell density was observed (Figure 4). The
increase in the low density fraction (<1.095 mg1') was
significant for all concentrations in human cells (P = 0.02,
0.03, and <0.01 for 5, 10, and 50mgI`). Again, the same
pattern of response was detected in the rat red cells. The
percentages of high density cells decreased from the un-
treated state for all concentrations (P<0.05).
Morphology studies
After exposure to low (10 mg1') or high (50 mg Il) concen-
trations of flunarizine, the most obvious shape change seen
was an increase in the number of stomatocytes, in both rat
and human blood (Figures 5a,b). The percent of stomato-
cytes observed rose from 12 + / - 2% in control conditions
to 26 + / - 8% and 68 + / - 7% in human cells exposed to
flunarizine in concentrations of 10 and 50 mg 1-', respec-
tively. Similarly, the percent of stomatocytes among the rat
RBC's rose from a control level of 19 + / - 2% to 29 + /
- 5% and 48 + / - 9% in the low and high concentration
exposures. Compared with baseline values in the absence of
flunarizine, the percentage was significantly higher for both
rat and human cells at the higher concentrations (P<0.001).
It was our impression that at the high dose level the rat red
cells became more spherical (sphero-stomatocytic) than
simply cup-shaped, although this effect could not be
quantified with the techniques employed.
Discussion
The effect of hypoxia per se as a factor impacting upon RBC
deformability has been debated. There have been reports
supporting (Gross & Hathaway, 1972; Lacelle & Weed, 1970)
and refuting (Brereton & Murphy, 1974; Hermann et al.,
1981; Usami et al., 1975) the hypothesis that hypoxia reduces
erythrocyte deformability. Also, species-to-species variability
in the effect of hypoxia on RBC deformability has been
reported. Rat RBC's in particular become significantly less
deformable at a P02 of 50 mmHg than at P02 of 150 mmHg
(Hakim & Macek, 1988), while other non-human species are
less affected. Most provocative in our opinion, though, is the
observation by De Cree et al. (1979) that in humans
flunarizine could prevent the measurable decrease in RBC
filterability in venous blood obtained after regional arterial
occlusion. Although P02 and pH are not reported in this
initial study, it is plausible that the ischemia produced by this
method in many ways models the poorly oxygenated and
acidotic reigons within solid tumour cores.
Extremes of hypoxia such as those found in tumours have
not been thoroughly examined. Although Koutsouris (1985)
reports no change in RBC deformability even at P02 Of
0 mmHg, the technique employed involved filtration through
5;m pores. Alterations in RBC deformability might not be
detected by filtration through pores this large, requiring in-EFFECTS OF FLUNARIZINE ON HYPOXIC RBCs 739
stead smaller apertures for the cells to transit to improve the
sensitivity of the test (Frank & Hochmuth, 1988). Further-
more, Koutsouris does not evaluate possible changes in RBC
density in extreme hypoxia. Frank and Hochmuth (1988) use
a Percoll gradient method to separate populations of red cells
according to density prior to testing deformability by a resis-
tive pulse technique. The denser subpopulations of aged cells
require significantly longer transit times through 5 and 6jLm
diameter pores because of increased resistance to shear defor-
mation due to a reduction in membrane surface area.
Osmotically shrunken cells, which are denser than normal
cells because of increased intracellular hemoglobin, similarly
have longer transit times through 3.6 and 5.0gm pores as a
result of increased shear viscosity of the membrane and
increased viscosity of the cytoplasm. In the present studies,
exposure of RBC's to PO2 below 10 mmHg causes a
significant increase in cell density, which corresponds to an
increase in suspension viscosity. Since iso-osmolar conditions
are maintained throughout, it appears more likely that
density increases under conditions of extreme hypoxia occur
by a mechanism of membrane damages similar to those
which occurs during cell senescence. However, the contribu-
tion to increased internal viscosity of any increase in intracel-
lular hemoglobin concentration has not specifically been
measured.
The most commonly reported effect of acidosis on red
blood cells is a net stiffening, presumably related to direct
effects on the mechanical properties of the membrane (e.g.
Crandall et al., 1978). However, it is also important to
consider the recognised cell volume increase which accom-
panies lowering pH (Rand et al., 1968). There appears to be
an optimal ratio of surface area to volume in order for the
cell to fold over onto itself most easily. Both rat RBC's, with
average mean cell volume (MCV) of 65 g3, and human
RBC's, with average MCV of 90 j3, demonstrate decreased
filterability with both osmotically induced shrinkage and
swelling when compared with optimal cell geometry (Norton
et al., 1981). Thus, depending upon where they lie in relation
to optimal proportions, a cell's baseline geometric dimensions
can influence whether its deformability goes up or down
following a slight cell volume increase such as that which can
result within an acidotic environment. Our observation of
decreased viscosity accompanied by reduced cell density in
acidotic conditions is likely a result of more optimal cell
surface area-to-volume ratio from the slight cell swelling.
Relatively little has been published concerning the isolated
effect of lactate on red cell deformability. Waldenlind et al.
(1988) report a significant decrease in RBC filterability at
normal pH with concentrations of lactate up to 3.6mMol
1-1, physiologically high levels comparable to those en-
countered in circulatory shock. Their suggested explanation
is a reaction occurring at the lactate receptor. If the effect
were reproducible, this phenomenon would at least partially
account for the observed decrease in RBC filterability when
supposedly 'hypoxic' conditions are produced by intense
muscular exercise in otherwise healthy individuals even if
actual low PO2 has not been documented (De Cree et al.,
1979; Guezennec et al., 1989). In such circumstances, there
has likely been considerable production of lactate: levels
ranging from 2-10 mMol [- have been measured in venous
blood even after submaximal exercise (Foxdal et al., 1990).
Note that similar lactic acid concentrations have been
measured within the interstitial fluid of implanted animal
tumours (Gullino et al., 1964). The reason for variability in
our present results is not entirely clear. It has been shown
that there is variability in rates of lactate metabolism among
normal healthy individuals (Fishbein et at., 1988), but inves-
tigations into this mechanism are beyond the scope of our
present experiments.
Flunarizine is a catamphiphilic molecule that has partic-
ular affinity for erythrocyte and other cellular lipid mem-
branes (Scheufler et al., 1990). The effect of the drug on
certain calcium-membrane interactions has been examined
electron microscopically. Flunarizine prevents the particle
aggregation, membrane aggregation, and blebbing which
would otherwise occur in the presence of elevated calcium
concentrations (Thomas et al., 1988). With regard to how the
drug might affect the shape of intact cell membranes,
Flameng et al. (1979) have documented the efficacy of flun-
arizine in suppressing discocyte-echinocyte transformation in
red blood cells subjected to cold temperatures. However, to
our knowledge the drug's pro-stomatocytogenic properties
per se have not previously been described.
There is a direct relationship between the calmodulin
inhibitory properties of numerous drugs and their ability to
generate 'cupped' erythrocytes or 'stomatocytes' (Nelson et
al., 1983). It is not clear precisely why such a shape change
occurs. Calcium-dependent binding of calmodulin to both
membrane-bound spectrin and to cytoplasmic cytoskeletal
proteins occurs; however, inhibition of these reactions by
calcium depletion fails to generate the same stomatocytosis
induced by the calmodulin antagonist trifluoroperazine
(Burns & Gratzer, 1985). A more direct inclusion of cal-
modulin inhibitors within the RBC membrane has been
postulated, consistent with the correlation of membrane
fluidisation and stomatocytosis as induced by several
qualitatively different methods (Noji et al., 1982). Flunarizine
inhibits calmodulin in vitro at a concentration of 4jiM, equal
to approximately 2 mg I' (Lugnier et al., 1984). In our
experiments the stomatocytogenic effect similarly suggests a
primary biochemical mechanism related to the characteristics
of a calmodulin' inhibitor.
Shape changes may influence RBC deformability in a vari-
ety of circumstances. Chlorpromazine, a stomatocytogenic
agent, prevents the echinocytic transformation generated by
ATP deletion. In a dose-dependent manner, the drug not
only prevents morphologic alteration, but also inhibits the
decrease in red cell suspension viscosity (measured by cone-
plate and oscillatory viscometers) produced by the
echinocytic transformation (Meiselman, 1981; Yardin &
Meiselman, 1989). Noji et al. use several different
stomatocytogenic calmodulin inhibitors to prevent loss of
erythrocyte deformability induced by ionophore-stimulated
intracellular calcium overload (Noji et al., 1987). Clark et al.
(1981) have suggested that ATP depletion causes impaired
deformability by indirectly leading to membrane damage
while calcium infusion produces the same effect by increasing
the cell's internal viscosity by osmotic changes; nevertheless,
treatment with stomatocytogenic agents appears to
counteract the impairment of deformability under either cir-
cumstance.
Besides morphological descriptors of shape changes, a
more quantitative way to characterise the effect of flunarizine
upon red blood cells is in terms of how the densities of a
population are changed after exposure to the drug. In the
present experiments, the viscosity of the RBC suspensions
was typically increased after exposure to conditions which
increased the proportion of cells of higher density, which are
known to be less deformable (Frank & Hochmuth, 1988). As
noted above, the higher density likely results from membrane
damage and surface area loss, possibly accompanied by net
loss of internal cell volume and consequent elevation of
intracellular hemoglobin. In the environment of hypoxia and
lactic acidosis, this change is prevented in human and rat
cells by flunarizine, which shifts cells into lower density frac-
tions. Effectively, the drug reconstitutes optimal cell
geometry, restoring the membrane and/or reducing cyto-
plasmic viscosity by causing slight cell swelling, thereby
reducing the hemoglobin concentration.
In the rat cells, however, the reduction in viscosity is lost
at high concentrations of flunarizine (50mgl1'). This is an
important point in relation to the observed pattern of dose-
response noted in measures of tumour blood flow and
radiosensitivity. Wood and Hirst (1989) have reported that
optimal radiosensitisation in implanted murine tumours
occurs at a dose of 5 mg kg-' administered intraperitoneally,
with the effect lessening at higher doses up to 500 mg kg-'.
Even the initial work at this university with intravenously
administered flunarizine suggests a somewhat similar biphasic
response pattern of increased blood flow to tumours at740 B.D. KAVANAGH et al.
optimal dosage (1 mg kg-') which diminished at a higher
dose (5 mg kg-') (Kaelin et al., 1984). Notice the two
different routes of administration are used in these studies
and that the former experiment was in mice and the latter in
rats. Increases in potency on the order of 6-8 times have
been described for other calcium channel blockers when com-
paring i.v. administration with oral or i.p. (Stone et al.,
1980). Pharmacokinetic studies in humans receiving oral
flunarizine have suggested that flunarizine similarly under-
goes significant first pass hepatic metabolism (Heykants et
al., 1979).
In consideration of such observations, we can interpret the
findings of our present studies in order to account for the
selective improvement in regional blood flow offered by
flunarizine within hypoxic tumour cores. In local conditions
of hypoxia and lactic acidosis, there can be an increase in
RBC density which decreases deformability ofindividual cells
and thus increases the effective blood viscosity in the area.
Flunarizine in low doses (5-OmgI1) protects against such
changes in both rat and human red cells. As the concentra-
tion of the drug is further increased, it appears that actual
cell swelling is induced in a dose dependent manner, as
evidenced by progressively reduced cell density. Human
RBC's tolerate flunarizine doses at least up to a concentra-
tion of 50 mg 1-' without excessive cell swelling to the point
ofdecrease in red cell deformability. Rat erythrocytes, on the
other hand, are much smaller initially; consequently, an in-
crease in cell volume of similar magnitude as in human cells
will cause a proportionally larger change in the cell's surface
area to volume ratio. It appears from our results that at a
flunarizine concentration of 50 mg 1', the rat RBC's have
swollen beyond optimal geometric proportions to a state
which is no more deformable than the dense condition in a
hypoxic environment. The morphological correlation is that
the rat cells go beyond stomatocytic to more overtly spherical
shape, a less deformable geometry.
Fenton and Sutherland (1992) have recently reported inter-
tumoural differences in changes in oxygen delivery caused by
flunarizine. Doses of flunarizine (5 mg kg-1) similar in mag-
nitude to the lower concentrations tested in our experiments
substantially improved oxygen delivery in KHT sarcomas
rather than in RIF-1 tumours implanted subcutaneously in
mice. Notably, the KHT tumours are more hypoxic initially
than the RIF-1, as demonstrated in their control tumours by
a lower percentage of blood vessels with at least 10% hemo-
globin saturation. These results are entirely consistent with
the mechanism of action demonstrated in our experiments.
Flunarizine is unlikely to improve upon the regional blood
flow within a tumour unless there is a reason (e.g. severe
hypoxia) why the red blood cells might be less deformable
locally within that region.
In summary, the results reported herein support the idea
that the milieu of the hypoxic centres of solid tumours can
produce loss of deformability of red blood cells. The drug
flunarizine has activity in these circumstances which is
characterised by stomatocytogenic changes in red cell mor-
phology, a shift toward lower proportions of the less defor-
mable high density (>1.105 gml-') red blood cells, and a
consequent reduction in the viscosity of bulk suspensions of
RBC's. Combined with the available data in animal models
documenting enhanced radiosensitivity in vivo with flunari-
zine, this explanation of the mechanism of activity has
encouraged us to pursue implementing the drug within the
context of an investigational protocol in human cancer
patients.
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